Tandem Diabetes Care | TNDM - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 10.4B 166M 2025-09
Accuray USD 91.79M 7.07M 2024-09
Align Technology USD 1.1B 2.38M 2025-12
AtriCure USD 66.65M 3.67M 2025-12
Baxter International USD 2.01B 231M 2025-12
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Boston Scientific USD 2.83B 13M 2025-09
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.28B 167.3M 2025-12
Edwards Lifesciences USD 892.8M 9.8M 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Globus Medical USD 743.66M 55.54M 2025-12
ICU Medical USD 180.52M 11.03M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 516.9M 54.7M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
Intuitive Surgical USD 1.53B 267.6M 2025-12
J&J USD 17.61B 235M 2025-09
Masimo USD 391.9M 36M 2025-12
Medtronic USD 6.36B 30M 2025-12
Merit Medical Systems USD 223.61M 7.9M 2025-12
Orthofix International USD 135.75M 4.94M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Stryker USD 4.04B 396M 2025-12
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 345.58M 247.07M 2025-12
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12